|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
ATE239797T1
(de)
|
1993-01-25 |
2003-05-15 |
Takeda Chemical Industries Ltd |
Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
|
|
JPH08295667A
(ja)
*
|
1995-04-27 |
1996-11-12 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法および剤
|
|
JPH08295687A
(ja)
*
|
1995-04-28 |
1996-11-12 |
Ube Ind Ltd |
無水シトラコン酸の製造法
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
DE69839808D1
(de)
|
1997-04-09 |
2008-09-11 |
Intellect Neurosciences Inc |
Für die termini des beta-amyloids spezifische, rekombinante antikörper, dafür kodierende dna und verfahren zu ihrer verwendung
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
JP2004509059A
(ja)
*
|
1999-06-03 |
2004-03-25 |
アボット・ラボラトリーズ |
細胞接着抑制性抗炎症化合物
|
|
AP1552A
(en)
|
1999-06-28 |
2006-01-17 |
Janssen Pharmaceutica Nv |
Respiratory syncytial virus replication inhibitors.
|
|
CZ20022353A3
(cs)
|
2000-01-07 |
2003-02-12 |
Universitaire Instelling Antwerpen |
Deriváty purinu, způsob jejich přípravy a jejich použití
|
|
CZ304211B6
(cs)
|
2000-02-24 |
2014-01-08 |
Washington University |
Humanizovaná protilátka, její fragment a jejich použití, polynukleová kyselina, expresní vektor, buňka a farmaceutický prostředek
|
|
ES2244613T3
(es)
|
2000-04-27 |
2005-12-16 |
Astellas Pharma Inc. |
Derivados de imidazopiridina.
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
EP1335738A4
(en)
|
2000-11-03 |
2004-09-08 |
Proteotech Inc |
METHOD FOR ISOLATING AMYLOID-INHIBITING COMPOUNDS AND USE OF COMPOUNDS ISOLATED FROM UNCARIA TOMENTOSA AND RELATED PLANTS
|
|
GB0115181D0
(en)
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
WO2003000697A1
(en)
|
2001-06-22 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Furoisoquinoline derivative, process for producing the same, and use
|
|
JP2005501822A
(ja)
|
2001-06-27 |
2005-01-20 |
メルク フロスト カナダ アンド カンパニー |
置換８−アリールキノリン系ｐｄｅ４阻害薬
|
|
WO2003002511A1
(en)
|
2001-06-29 |
2003-01-09 |
Nikken Chemicals Co., Ltd. |
Cycloalkenone derivative
|
|
WO2003008396A1
(en)
|
2001-07-16 |
2003-01-30 |
Nikken Chemicals Co., Ltd. |
Optically active oxazine derivative
|
|
US7485639B2
(en)
|
2001-07-18 |
2009-02-03 |
Merck Patent Gmbh |
4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergies
|
|
WO2003008373A1
(de)
|
2001-07-19 |
2003-01-30 |
Merck Patent Gmbh |
Tyrosinhydrazide
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
GB0118373D0
(en)
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
TWI221838B
(en)
|
2001-08-09 |
2004-10-11 |
Tanabe Seiyaku Co |
Pyrazinoisoquinoline compound or naphthalene compound
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
FR2828693B1
(fr)
|
2001-08-14 |
2004-06-18 |
Exonhit Therapeutics Sa |
Nouvelle cible moleculaire de la neurotoxicite
|
|
WO2003015789A2
(en)
|
2001-08-15 |
2003-02-27 |
Leo Pharma A/S |
A pharmaceutical composition for dermal application
|
|
AU2002331621B2
(en)
|
2001-08-15 |
2008-06-05 |
Icos Corporation |
2H-phthalazin-1-ones and methods for use thereof
|
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
|
GB0122031D0
(en)
|
2001-09-12 |
2001-10-31 |
Pfizer Ltd |
Use of pde4 inhibitors in a dry powder inhaler
|
|
EA007736B1
(ru)
|
2001-09-19 |
2006-12-29 |
Алтана Фарма Аг |
Комбинация ингибитора pde и антагониста лейкотриенового рецептора
|
|
PT1429807E
(pt)
|
2001-09-19 |
2007-05-31 |
Altana Pharma Ag |
Combinação de um nsaid e de um inibidor de pde-4
|
|
WO2003035650A1
(en)
|
2001-09-25 |
2003-05-01 |
Takeda Chemical Industries, Ltd. |
Entry inhibitor
|
|
NZ531786A
(en)
|
2001-10-02 |
2006-10-27 |
Upjohn Co |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
GB0123951D0
(en)
|
2001-10-05 |
2001-11-28 |
Glaxo Group Ltd |
Therapies for treating respiratory diseases
|
|
DE10150517A1
(de)
|
2001-10-12 |
2003-04-17 |
Merck Patent Gmbh |
Verwendung von Phosphodiesterase IV-Inhibitoren
|
|
EP1435944B1
(en)
|
2001-10-16 |
2009-09-30 |
Memory Pharmaceutical Corporation |
4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
|
AU2002343604C1
(en)
|
2001-10-30 |
2009-09-17 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
|
US20040259863A1
(en)
|
2001-10-31 |
2004-12-23 |
Hans-Michael Eggenweiler |
Type 4 phosphodiesterase inhibitors and uses thereof
|
|
ATE541847T1
(de)
|
2001-11-01 |
2012-02-15 |
Icagen Inc |
Pyrazolopyrimidine als natriumkanalblocker
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
RU2302412C2
(ru)
|
2001-11-05 |
2007-07-10 |
Мерк Патент Гмбх |
Гидразоно-малонитрилы
|
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
|
US20030092706A1
(en)
|
2001-11-09 |
2003-05-15 |
Johannes Barsig |
Combination
|
|
IS7221A
(is)
|
2001-11-15 |
2004-04-15 |
Memory Pharmaceuticals Corporation |
Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra
|
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
|
US20050101000A1
(en)
|
2002-12-11 |
2005-05-12 |
Isis Pharmaceuticals Inc. |
Modulation of phosphodiesterase 4B expression
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
US20040146512A1
(en)
|
2002-10-09 |
2004-07-29 |
Arnon Rosenthal |
Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
WO2004042390A2
(en)
|
2002-11-08 |
2004-05-21 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
|
|
AU2003299651A1
(en)
|
2002-12-11 |
2004-06-30 |
Merck And Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
|
DK1615647T3
(da)
|
2003-04-11 |
2010-04-06 |
High Point Pharmaceuticals Llc |
Farmaceutisk anvendelse af kondenserede 1,2,4-triazoler
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
US7741341B2
(en)
|
2003-05-19 |
2010-06-22 |
Sanofi-Aventis Deutschland Gmbh |
Benzimidazole-derivatives as factor Xa inhibitors
|
|
CA2528652A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
US20060148805A1
(en)
|
2003-07-01 |
2006-07-06 |
Meng Hsin Chen |
Opthalmic compositions for treating ocular hypertension
|
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
US20050020587A1
(en)
|
2003-07-25 |
2005-01-27 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
EP1666061A1
(en)
|
2003-09-09 |
2006-06-07 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
GB0322726D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
NZ546521A
(en)
|
2003-09-29 |
2009-09-25 |
Topigen Pharma Inc |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
WO2005066151A2
(en)
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
CA2555071A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
|
JP2008503446A
(ja)
|
2004-05-06 |
2008-02-07 |
プレキシコン，インコーポレーテッド |
Ｐｄｅ４ｂ阻害剤及びその使用
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
EA016357B1
(ru)
|
2004-07-30 |
2012-04-30 |
Ринат Ньюросайенс Корп. |
Антитела, направленные против бета-амилоидного пептида, и способы их применения
|
|
CN101048407A
(zh)
|
2004-09-03 |
2007-10-03 |
普莱希科公司 |
双环杂芳基pde4b抑制剂
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
AR051294A1
(es)
|
2004-09-20 |
2007-01-03 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
|
EP1809294A4
(en)
|
2004-09-21 |
2008-08-06 |
Synta Pharmaceuticals Corp |
COMPOUNDS AGAINST INFLAMMATION AND IMMUNE-RELEVANT USES
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
DE102004054634A1
(de)
*
|
2004-11-12 |
2006-05-18 |
Schwarz Pharma Ag |
Azaindolcarboxamide
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
EP1849465A4
(en)
|
2005-02-18 |
2008-12-24 |
Takeda Pharmaceutical |
AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR
|
|
GB0503955D0
(en)
|
2005-02-25 |
2005-04-06 |
Glaxo Group Ltd |
Novel compounds
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
AU2006245416B2
(en)
|
2005-05-12 |
2012-02-23 |
Pfizer Inc. |
Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
|
WO2006126082A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
ATE488496T1
(de)
|
2005-06-22 |
2010-12-15 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
JP2009514846A
(ja)
|
2005-11-04 |
2009-04-09 |
ファイザー・リミテッド |
テトラヒドロナフチリジン誘導体
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
WO2007105053A2
(en)
|
2006-03-13 |
2007-09-20 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
|
GB0605462D0
(en)
|
2006-03-17 |
2006-04-26 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2013208B1
(en)
|
2006-04-21 |
2011-06-22 |
Pfizer Products Inc. |
Pyridin[3,4-b]pyrazinones
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
MX2009000148A
(es)
|
2006-07-07 |
2009-10-26 |
Kalypsys Inc |
Inhibidores heteroaril biciclicos de fosfodiesterasa 4.
|
|
US8138205B2
(en)
|
2006-07-07 |
2012-03-20 |
Kalypsys, Inc. |
Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
|
|
BRPI0714622A2
(pt)
|
2006-08-04 |
2013-04-30 |
Merz Pharma Gmbh & Co Kgaa |
pirazolopirimidinas substituÍdas, processo para sua preparaÇço e seu uso como medicamento
|
|
EP1900739A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Diazolodiazine derivatives as kinase inhibitors
|
|
WO2008033739A2
(en)
*
|
2006-09-12 |
2008-03-20 |
Neurogen Corporation |
Benzimidazole carboxamide derivatives
|
|
US20090275586A1
(en)
|
2006-10-06 |
2009-11-05 |
Kalypsys, Inc. |
Heterocyclic inhibitors of pde4
|
|
US20100105729A1
(en)
|
2006-10-06 |
2010-04-29 |
Kalypsys, Inc. |
Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents
|
|
US20080102475A1
(en)
|
2006-10-13 |
2008-05-01 |
Zhengyan Kan |
Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
|
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
|
WO2008056176A1
(en)
|
2006-11-10 |
2008-05-15 |
Scottish Biomedical Limited |
Pyrazolopyrimidines as phosphodiesterase inhibitors
|
|
BRPI0806473A2
(pt)
|
2007-01-22 |
2011-09-27 |
Pfizer Prod Inc |
sal de tosilato de um composto terapêutico e composições farmacêuticas do mesmo
|
|
JP2010535816A
(ja)
|
2007-08-10 |
2010-11-25 |
ハー・ルンドベック・アクチエゼルスカベット |
ヘテロアリールアミド類似体
|
|
EP2187883A2
(en)
|
2007-08-10 |
2010-05-26 |
Genelabs Technologies, Inc. |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
WO2009108551A2
(en)
|
2008-02-25 |
2009-09-03 |
H. Lundbeck A/S |
Heteroaryl amide analogues
|
|
GB2461702A
(en)
|
2008-07-08 |
2010-01-13 |
Dyson Technology Ltd |
Hand drying apparatus
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
JP2012503623A
(ja)
|
2008-09-24 |
2012-02-09 |
ビーエーエスエフ ソシエタス・ヨーロピア |
無脊椎動物系害虫防除用ピラゾール化合物
|
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
US8552051B2
(en)
|
2009-03-20 |
2013-10-08 |
H. L. Hall & Sons Limited |
Use of pharmaceutical compositions containing mesembrenone
|
|
JP5641664B2
(ja)
|
2009-10-30 |
2014-12-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
イミダゾ［１，２−ｂ］ピリダジン誘導体およびＰＤＥ１０阻害剤としてのそれらの使用
|
|
US20120283274A1
(en)
|
2009-11-25 |
2012-11-08 |
Patrick Plitt |
Crystalline forms of substituted pyrazolopyrimidines
|
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
|
CA2792339A1
(en)
|
2010-03-23 |
2011-09-29 |
High Point Pharmaceuticals, Llc |
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
|
|
WO2011143106A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bi - functional pyrazolopyridine compounds
|
|
US8394829B2
(en)
|
2010-05-10 |
2013-03-12 |
Gilead Sciences, Inc. |
Bi-functional quinoline analogs
|
|
WO2012067822A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
|
WO2013028263A1
(en)
|
2011-08-24 |
2013-02-28 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as pi3 kinase inhibitors
|
|
BR112015019276A2
(pt)
|
2013-02-19 |
2017-07-18 |
Pfizer |
compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
|
|
US9193736B2
(en)
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
GB201321734D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
US11497586B2
(en)
|
2014-03-21 |
2022-11-15 |
Align Technology, Inc. |
Segmented orthodontic appliance with elastics
|
|
WO2016012896A1
(en)
|
2014-07-24 |
2016-01-28 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
|
DK3177624T3
(da)
|
2014-08-06 |
2019-07-01 |
Pfizer |
Imidazopyridazinforbindelser
|